Xylem (NYSE: XYL) reported Q4 EPS of $0.63, $0.01 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.31 billion.

GUIDANCE:

Xylem sees FY2022 EPS of $2.35-$2.70, versus the consensus of $2.47.

For earnings history and earnings-related data on Xylem (XYL) click here.